NO761942L - - Google Patents

Info

Publication number: NO761942L
Authority: NO; Norway
Prior art keywords: group; compound; formula; hydrogen atom; methyl
Prior art date: 1975-06-09

Application number

NO761942A

Other languages

English (en)

Norwegian (no)

Inventor

P A E Carlsson

P L Lindberg

B V Wickberg

Original Assignee

Astra Laekemedel Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1975-06-09

Filing date

1976-06-08

Publication date

1976-12-10

1976-06-08 Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab

1976-12-10 Publication of NO761942L publication Critical patent/NO761942L/no

Links

150000001875 compounds Chemical class 0.000 claims description 98
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 85
238000000034 method Methods 0.000 claims description 43
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 42
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 42
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 35
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 34
150000003839 salts Chemical class 0.000 claims description 19
239000002253 acid Substances 0.000 claims description 13
125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 claims description 12
229910052739 hydrogen Inorganic materials 0.000 claims description 11
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 11
238000002360 preparation method Methods 0.000 claims description 11
125000003277 amino group Chemical group 0.000 claims description 9
239000001257 hydrogen Substances 0.000 claims description 9
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 7
238000005341 cation exchange Methods 0.000 claims description 7
238000004587 chromatography analysis Methods 0.000 claims description 7
238000004519 manufacturing process Methods 0.000 claims description 7
125000000217 alkyl group Chemical group 0.000 claims description 6
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 5
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 5
239000000825 pharmaceutical preparation Substances 0.000 claims description 5
OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 4
125000004432 carbon atom Chemical group C* 0.000 claims description 4
PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 claims description 3
235000001674 Agaricus brunnescens Nutrition 0.000 claims description 3
238000002425 crystallisation Methods 0.000 claims description 3
230000008025 crystallization Effects 0.000 claims description 3
238000011065 in-situ storage Methods 0.000 claims description 3
239000000463 material Substances 0.000 claims description 3
230000020477 pH reduction Effects 0.000 claims description 3
208000007848 Alcoholism Diseases 0.000 claims description 2
241001236122 Coprinopsis atramentaria Species 0.000 claims description 2
238000005903 acid hydrolysis reaction Methods 0.000 claims description 2
239000004480 active ingredient Substances 0.000 claims description 2
201000007930 alcohol dependence Diseases 0.000 claims description 2
238000005904 alkaline hydrolysis reaction Methods 0.000 claims description 2
125000003545 alkoxy group Chemical group 0.000 claims description 2
125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims description 2
239000003085 diluting agent Substances 0.000 claims description 2
239000003937 drug carrier Substances 0.000 claims description 2
239000000469 ethanolic extract Substances 0.000 claims description 2
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
KFUSIRMDWATCKL-UHFFFAOYSA-N 1-aminocyclopropan-1-ol Chemical class NC1(O)CC1 KFUSIRMDWATCKL-UHFFFAOYSA-N 0.000 claims 1
241000238366 Cephalopoda Species 0.000 claims 1
125000000129 anionic group Chemical group 0.000 claims 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
239000002195 soluble material Substances 0.000 claims 1
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 44
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 39
239000000243 solution Substances 0.000 description 33
AUZONCFQVSMFAP-UHFFFAOYSA-N disulfiram Chemical compound CCN(CC)C(=S)SSC(=S)N(CC)CC AUZONCFQVSMFAP-UHFFFAOYSA-N 0.000 description 32
239000000203 mixture Substances 0.000 description 30
HTECWCYCEGPEEU-UHFFFAOYSA-N (1-hydroxycyclopropyl)azanium;chloride Chemical compound Cl.NC1(O)CC1 HTECWCYCEGPEEU-UHFFFAOYSA-N 0.000 description 29
IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 24
238000005481 NMR spectroscopy Methods 0.000 description 22
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 22
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 19
OEEZRBUCLFMTLD-UHFFFAOYSA-N coprine Natural products OC(=O)C(N)CCC(=O)NC1(O)CC1 OEEZRBUCLFMTLD-UHFFFAOYSA-N 0.000 description 19
239000000706 filtrate Substances 0.000 description 19
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
229960002563 disulfiram Drugs 0.000 description 16
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
238000001704 evaporation Methods 0.000 description 15
230000008020 evaporation Effects 0.000 description 15
241000700159 Rattus Species 0.000 description 14
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 13
230000037396 body weight Effects 0.000 description 13
239000002244 precipitate Substances 0.000 description 13
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 12
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
238000006243 chemical reaction Methods 0.000 description 11
230000000694 effects Effects 0.000 description 11
238000002474 experimental method Methods 0.000 description 11
-1 t-butoxy Chemical group 0.000 description 11
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
229920001429 chelating resin Polymers 0.000 description 10
238000003756 stirring Methods 0.000 description 9
GVKBESBSOODNQP-UHFFFAOYSA-N 1-ethoxycyclopropan-1-amine;hydrochloride Chemical compound [Cl-].CCOC1([NH3+])CC1 GVKBESBSOODNQP-UHFFFAOYSA-N 0.000 description 8
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 8
OEEZRBUCLFMTLD-YFKPBYRVSA-N coprine Chemical compound OC(=O)[C@@H](N)CCC(=O)NC1(O)CC1 OEEZRBUCLFMTLD-YFKPBYRVSA-N 0.000 description 8
229920006395 saturated elastomer Polymers 0.000 description 8
239000007789 gas Substances 0.000 description 7
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
239000002585 base Substances 0.000 description 6
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 6
239000000047 product Substances 0.000 description 6
238000001953 recrystallisation Methods 0.000 description 6
IEPAHAXVBXNSKS-UHFFFAOYSA-N 1-methoxycyclopropan-1-amine;hydrochloride Chemical compound [Cl-].COC1([NH3+])CC1 IEPAHAXVBXNSKS-UHFFFAOYSA-N 0.000 description 5
108010010803 Gelatin Proteins 0.000 description 5
235000019270 ammonium chloride Nutrition 0.000 description 5
238000005349 anion exchange Methods 0.000 description 5
239000008273 gelatin Substances 0.000 description 5
229920000159 gelatin Polymers 0.000 description 5
235000019322 gelatine Nutrition 0.000 description 5
235000011852 gelatine desserts Nutrition 0.000 description 5
239000003921 oil Substances 0.000 description 5
235000019198 oils Nutrition 0.000 description 5
229960003732 tyramine Drugs 0.000 description 5
REVHXXJMIPNUIG-UHFFFAOYSA-N 1-ethoxy-1-isocyanatocyclopropane Chemical compound CCOC1(N=C=O)CC1 REVHXXJMIPNUIG-UHFFFAOYSA-N 0.000 description 4
DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
235000011054 acetic acid Nutrition 0.000 description 4
230000002378 acidificating effect Effects 0.000 description 4
239000008346 aqueous phase Substances 0.000 description 4
239000007864 aqueous solution Substances 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
239000002775 capsule Substances 0.000 description 4
239000001913 cellulose Substances 0.000 description 4
229920002678 cellulose Polymers 0.000 description 4
235000013922 glutamic acid Nutrition 0.000 description 4
239000004220 glutamic acid Substances 0.000 description 4
230000005764 inhibitory process Effects 0.000 description 4
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 4
239000007787 solid Substances 0.000 description 4
239000002904 solvent Substances 0.000 description 4
NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 3
OZEXGTLFJIEFPB-UHFFFAOYSA-N 1-[(1-hydroxycyclopropyl)amino]cyclopropan-1-ol;hydrochloride Chemical compound [Cl-].C1CC1(O)[NH2+]C1(O)CC1 OZEXGTLFJIEFPB-UHFFFAOYSA-N 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 3
150000001412 amines Chemical class 0.000 description 3
235000001014 amino acid Nutrition 0.000 description 3
229940024606 amino acid Drugs 0.000 description 3
150000001413 amino acids Chemical class 0.000 description 3
235000011114 ammonium hydroxide Nutrition 0.000 description 3
235000003704 aspartic acid Nutrition 0.000 description 3
PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 3
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 3
238000001816 cooling Methods 0.000 description 3
229920001971 elastomer Polymers 0.000 description 3
CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical compound C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 description 3
239000000284 extract Substances 0.000 description 3
238000000605 extraction Methods 0.000 description 3
238000001914 filtration Methods 0.000 description 3
IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 3
239000012535 impurity Substances 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
238000002955 isolation Methods 0.000 description 3
239000007788 liquid Substances 0.000 description 3
238000005259 measurement Methods 0.000 description 3
FPGXZNPYIAXPCL-UHFFFAOYSA-N n-(1-hydroxycyclopropyl)acetamide Chemical compound CC(=O)NC1(O)CC1 FPGXZNPYIAXPCL-UHFFFAOYSA-N 0.000 description 3
XFTMSAPNGBJRPS-UHFFFAOYSA-N n-(1-hydroxycyclopropyl)benzamide Chemical compound C=1C=CC=CC=1C(=O)NC1(O)CC1 XFTMSAPNGBJRPS-UHFFFAOYSA-N 0.000 description 3
IWTMRYLZIDOZHL-UHFFFAOYSA-N n-[(4-methylphenyl)sulfonylmethyl]methanimine Chemical compound CC1=CC=C(S(=O)(=O)CN=C)C=C1 IWTMRYLZIDOZHL-UHFFFAOYSA-N 0.000 description 3
229960001576 octopamine Drugs 0.000 description 3
239000003960 organic solvent Substances 0.000 description 3
125000000612 phthaloyl group Chemical group C(C=1C(C(=O)*)=CC=CC1)(=O)* 0.000 description 3
235000019260 propionic acid Nutrition 0.000 description 3
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 3
229910000029 sodium carbonate Inorganic materials 0.000 description 3
239000007858 starting material Substances 0.000 description 3
CCBAQMIMSNBKGE-UHFFFAOYSA-N 1-piperidin-1-ylcyclopropan-1-ol Chemical compound C1CCCCN1C1(O)CC1 CCBAQMIMSNBKGE-UHFFFAOYSA-N 0.000 description 2
QHOINBKBMJLHPY-UHFFFAOYSA-N 2-chloroethyl formate Chemical compound ClCCOC=O QHOINBKBMJLHPY-UHFFFAOYSA-N 0.000 description 2
VOZOQWOUOOVFSB-UHFFFAOYSA-N 6-(trifluoromethyl)-2h-isoquinolin-1-one Chemical compound C1=CNC(=O)C=2C1=CC(C(F)(F)F)=CC=2 VOZOQWOUOOVFSB-UHFFFAOYSA-N 0.000 description 2
108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 2
102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 2
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
229920000945 Amylopectin Polymers 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
229920002261 Corn starch Polymers 0.000 description 2
XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 2
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
229930195725 Mannitol Natural products 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
150000008065 acid anhydrides Chemical class 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
229910021529 ammonia Inorganic materials 0.000 description 2
150000008064 anhydrides Chemical class 0.000 description 2
229960001230 asparagine Drugs 0.000 description 2
235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
239000008120 corn starch Substances 0.000 description 2
YOXHCYXIAVIFCZ-UHFFFAOYSA-N cyclopropanol Chemical class OC1CC1 YOXHCYXIAVIFCZ-UHFFFAOYSA-N 0.000 description 2
238000002086 displacement chromatography Methods 0.000 description 2
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 2
239000007903 gelatin capsule Substances 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
239000000543 intermediate Substances 0.000 description 2
239000008101 lactose Substances 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
239000000594 mannitol Substances 0.000 description 2
235000010355 mannitol Nutrition 0.000 description 2
TUJUPTAJHFFHJT-UHFFFAOYSA-N n-(1-ethoxycyclopropyl)benzamide Chemical compound C=1C=CC=CC=1C(=O)NC1(OCC)CC1 TUJUPTAJHFFHJT-UHFFFAOYSA-N 0.000 description 2
BRJUTYANKBFKQS-UHFFFAOYSA-N n-(1-methoxycyclopropyl)benzamide Chemical compound C=1C=CC=CC=1C(=O)NC1(OC)CC1 BRJUTYANKBFKQS-UHFFFAOYSA-N 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 2
231100000252 nontoxic Toxicity 0.000 description 2
230000003000 nontoxic effect Effects 0.000 description 2
239000012074 organic phase Substances 0.000 description 2
VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
239000003208 petroleum Substances 0.000 description 2
230000000144 pharmacologic effect Effects 0.000 description 2
239000012071 phase Substances 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
229920001592 potato starch Polymers 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
239000012312 sodium hydride Substances 0.000 description 2
229910000104 sodium hydride Inorganic materials 0.000 description 2
239000000600 sorbitol Substances 0.000 description 2
235000010356 sorbitol Nutrition 0.000 description 2
238000013222 sprague-dawley male rat Methods 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
IIACRCGMVDHOTQ-UHFFFAOYSA-M sulfamate Chemical compound NS([O-])(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-M 0.000 description 2
239000000725 suspension Substances 0.000 description 2
229940095064 tartrate Drugs 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
DZGWFCGJZKJUFP-UHFFFAOYSA-N tyramine Chemical compound NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 description 2
235000015112 vegetable and seed oil Nutrition 0.000 description 2
239000008158 vegetable oil Substances 0.000 description 2
238000005406 washing Methods 0.000 description 2
HQUPZHZRIMXFRS-UHFFFAOYSA-N (1-hydroxycyclopropyl) acetate Chemical compound CC(=O)OC1(O)CC1 HQUPZHZRIMXFRS-UHFFFAOYSA-N 0.000 description 1
BDCJMHUZOPZFBF-UHFFFAOYSA-N 1,3-bis(1-ethoxycyclopropyl)urea Chemical compound C1CC1(OCC)NC(=O)NC1(OCC)CC1 BDCJMHUZOPZFBF-UHFFFAOYSA-N 0.000 description 1
MRNFREDWQAFPPS-UHFFFAOYSA-N 1-[(1-hydroxycyclopropyl)amino]cyclopropan-1-ol Chemical compound C1CC1(O)NC1(O)CC1 MRNFREDWQAFPPS-UHFFFAOYSA-N 0.000 description 1
WNQCYLOWQRCYOV-UHFFFAOYSA-N 1-ethoxycyclopropan-1-amine Chemical compound CCOC1(N)CC1 WNQCYLOWQRCYOV-UHFFFAOYSA-N 0.000 description 1
DILXLMRYFWFBGR-UHFFFAOYSA-N 2-formylbenzene-1,4-disulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(S(O)(=O)=O)C(C=O)=C1 DILXLMRYFWFBGR-UHFFFAOYSA-N 0.000 description 1
IHPRVZKJZGXTBQ-UHFFFAOYSA-N 3-chloropropan-1-amine;hydron;chloride Chemical compound Cl.NCCCCl IHPRVZKJZGXTBQ-UHFFFAOYSA-N 0.000 description 1
244000215068 Acacia senegal Species 0.000 description 1
229940097693 Aldehyde dehydrogenase inhibitor Drugs 0.000 description 1
206010006326 Breath odour Diseases 0.000 description 1
XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 1
YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
108010015720 Dopamine beta-Hydroxylase Proteins 0.000 description 1
102100033156 Dopamine beta-hydroxylase Human genes 0.000 description 1
241000233866 Fungi Species 0.000 description 1
229920000084 Gum arabic Polymers 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
239000005662 Paraffin oil Substances 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
208000032140 Sleepiness Diseases 0.000 description 1
206010041349 Somnolence Diseases 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
239000000205 acacia gum Substances 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
239000003187 aldehyde dehydrogenase inhibitor Substances 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
150000001540 azides Chemical class 0.000 description 1
235000019445 benzyl alcohol Nutrition 0.000 description 1
125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
150000001649 bromium compounds Chemical class 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
239000008116 calcium stearate Substances 0.000 description 1
235000013539 calcium stearate Nutrition 0.000 description 1
150000001718 carbodiimides Chemical class 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
239000000969 carrier Substances 0.000 description 1
239000012159 carrier gas Substances 0.000 description 1
229920006184 cellulose methylcellulose Polymers 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
150000001805 chlorine compounds Chemical class 0.000 description 1
238000000576 coating method Methods 0.000 description 1
239000003086 colorant Substances 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
ZJAPOEKGBGSNBG-UHFFFAOYSA-N cyclopropane-1,1-diol Chemical compound OC1(O)CC1 ZJAPOEKGBGSNBG-UHFFFAOYSA-N 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
WVPKAWVFTPWPDB-UHFFFAOYSA-N dichlorophosphinic acid Chemical compound OP(Cl)(Cl)=O WVPKAWVFTPWPDB-UHFFFAOYSA-N 0.000 description 1
238000004821 distillation Methods 0.000 description 1
229960003638 dopamine Drugs 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
210000003238 esophagus Anatomy 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
239000012065 filter cake Substances 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
239000012458 free base Substances 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
239000008187 granular material Substances 0.000 description 1
ALBYIUDWACNRRB-UHFFFAOYSA-N hexanamide Chemical class CCCCCC(N)=O ALBYIUDWACNRRB-UHFFFAOYSA-N 0.000 description 1
YWGHUJQYGPDNKT-UHFFFAOYSA-N hexanoyl chloride Chemical compound CCCCCC(Cl)=O YWGHUJQYGPDNKT-UHFFFAOYSA-N 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
238000005805 hydroxylation reaction Methods 0.000 description 1
JBFYUZGYRGXSFL-UHFFFAOYSA-N imidazolide Chemical compound C1=C[N-]C=N1 JBFYUZGYRGXSFL-UHFFFAOYSA-N 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000009413 insulation Methods 0.000 description 1
239000013067 intermediate product Substances 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
SBOJXQVPLKSXOG-UHFFFAOYSA-N o-amino-hydroxylamine Chemical compound NON SBOJXQVPLKSXOG-UHFFFAOYSA-N 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
229920000053 polysorbate 80 Polymers 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
102220212642 rs747431847 Human genes 0.000 description 1
235000019204 saccharin Nutrition 0.000 description 1
CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
229940081974 saccharin Drugs 0.000 description 1
239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
210000003079 salivary gland Anatomy 0.000 description 1
239000012266 salt solution Substances 0.000 description 1
239000013049 sediment Substances 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
230000037321 sleepiness Effects 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
229910052938 sodium sulfate Inorganic materials 0.000 description 1
235000011152 sodium sulphate Nutrition 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
238000000859 sublimation Methods 0.000 description 1
230000008022 sublimation Effects 0.000 description 1
239000000126 substance Substances 0.000 description 1
BUUPQKDIAURBJP-UHFFFAOYSA-N sulfinic acid Chemical compound OS=O BUUPQKDIAURBJP-UHFFFAOYSA-N 0.000 description 1
229910021653 sulphate ion Inorganic materials 0.000 description 1
239000000829 suppository Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000006188 syrup Substances 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
235000008521 threonine Nutrition 0.000 description 1
239000004408 titanium dioxide Substances 0.000 description 1
210000000689 upper leg Anatomy 0.000 description 1
239000002966 varnish Substances 0.000 description 1
239000001993 wax Substances 0.000 description 1
238000005303 weighing Methods 0.000 description 1
BLGXFZZNTVWLAY-SCYLSFHTSA-N yohimbine Chemical compound C1=CC=C2C(CCN3C[C@@H]4CC[C@H](O)[C@@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-SCYLSFHTSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic
- C07C35/04—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic containing a three or four-membered rings
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Biotechnology (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NO761942A 1975-06-09 1976-06-08 NO761942L (xx)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE7506546A SE404186B (sv)	1975-06-09	1975-06-09	Forfarande for framstellning av cyklopropanolderivat

Publications (1)

Publication Number	Publication Date
NO761942L true NO761942L (xx)	1976-12-10

Family

ID=20324800

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO761942A NO761942L (xx)	1975-06-09	1976-06-08

Country Status (15)

Country	Link
US (1)	US4076840A (xx)
JP (1)	JPS51146438A (xx)
AU (1)	AU1468176A (xx)
BE (1)	BE842716A (xx)
DE (1)	DE2625110A1 (xx)
DK (1)	DK251176A (xx)
ES (1)	ES448645A1 (xx)
FI (1)	FI761628A (xx)
FR (1)	FR2354762A1 (xx)
LU (1)	LU75122A1 (xx)
NL (1)	NL7606238A (xx)
NO (1)	NO761942L (xx)
NZ (1)	NZ181088A (xx)
SE (1)	SE404186B (xx)
SU (1)	SU608470A3 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4098904A (en) *	1976-11-12	1978-07-04	The Upjohn Company	Analgesic n-(2-aminocycloaliphatic)benzamides
CA1117127A (en) *	1978-06-27	1982-01-26	Janet A. Day	Derivatives of 3-azabicyclo(3.1.0)hexane and a process for their preparation
DE2948024A1 (de) *	1979-11-29	1981-08-27	Bayer Ag, 5090 Leverkusen	1-amino-cyclopropancarbonsaeure-derivate, verfahren zu ihrer herstellung und ihre verwendung als pflanzenwachstumsregulatoren
PT1441708E (pt)	2001-11-05	2009-06-18	Krele Pharmaceuticals Llc	Composições e métodos para aumentar a observância de terapias utilizando inibidores da aldeído desidrogenase e para tratar alcoolismo
CA2809966C (en)	2010-09-01	2019-01-08	Tonix Pharmaceuticals, Inc.	Treatment for ***e addiction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1251755B (de) *	1960-10-17	1967-10-12	Smith Kline &. French Laboratories, Philadelphia, Pa (V St A)	Verfahren zur Herstellung von 2 Phenyl-cyclopropyl carbaminsaurederivaten
US3954778A (en) *	1970-03-03	1976-05-04	Zambon S.P.A.	Aminoacetyl derivatives of 2,3-diphenyl cyclopropyl amine

1975
- 1975-06-09 SE SE7506546A patent/SE404186B/xx unknown
1976
- 1976-05-25 US US05/689,824 patent/US4076840A/en not_active Expired - Lifetime
- 1976-06-04 DE DE19762625110 patent/DE2625110A1/de active Pending
- 1976-06-07 AU AU14681/76A patent/AU1468176A/en not_active Expired
- 1976-06-08 DK DK251176A patent/DK251176A/da unknown
- 1976-06-08 SU SU762369252A patent/SU608470A3/ru active
- 1976-06-08 FI FI761628A patent/FI761628A/fi not_active Application Discontinuation
- 1976-06-08 ES ES448645A patent/ES448645A1/es not_active Expired
- 1976-06-08 NO NO761942A patent/NO761942L/no unknown
- 1976-06-08 NZ NZ181088A patent/NZ181088A/xx unknown
- 1976-06-09 FR FR7617399A patent/FR2354762A1/fr active Pending
- 1976-06-09 NL NL7606238A patent/NL7606238A/xx not_active Application Discontinuation
- 1976-06-09 BE BE167724A patent/BE842716A/xx unknown
- 1976-06-09 LU LU75122A patent/LU75122A1/xx unknown
- 1976-06-09 JP JP51066638A patent/JPS51146438A/ja active Pending

Also Published As

Publication number	Publication date
DE2625110A1 (de)	1977-01-13
US4076840A (en)	1978-02-28
BE842716A (fr)	1976-12-09
NZ181088A (en)	1978-06-02
ES448645A1 (es)	1977-12-01
FR2354762A1 (fr)	1978-01-13
SE7506546L (sv)	1976-12-10
AU1468176A (en)	1977-12-15
DK251176A (da)	1976-12-10
JPS51146438A (en)	1976-12-16
SU608470A3 (ru)	1978-05-25
NL7606238A (nl)	1976-12-13
FI761628A (xx)	1976-12-10
LU75122A1 (xx)	1977-03-10
SE404186B (sv)	1978-09-25

Publication	Publication Date	Title
EP2970123B1 (en)	2019-08-14	Salt of omecamtiv mecarbil and process for preparing salt
NO152130B (no)	1985-04-29	Analogifremgangsmaate for fremstilling av bronchospasmolytisk virksomme forbindelser
IL228677A (en)	2017-06-29	Branched and used 3-phenylpropionic acid history
ZA200510294B (en)	2006-12-27	Hexahydropyridoisoquinolines as DPP-IV inhibitors
CZ150596A3 (en)	1997-05-14	Tetrahydrocarbazole derivatives, process of their preparation and pharmaceutical compositions containing thereof
NO160778B (no)	1989-02-20	Analogifremgangsmaate ved fremstilling av nye antifibrinolytisk aktive tranexaminsyreestere.
IE47635B1 (en)	1984-05-16	Phenylglycine derivatives
EP0374095A2 (de)	1990-06-20	Piperidinderivate
PL79309B1 (xx)	1975-06-30
US4855422A (en)	1989-08-08	Process for the preparation of azoniaspironortropanol esters
NO761942L (xx)	1976-12-10
US8188126B2 (en)	2012-05-29	Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
WO1997026242A1 (fr)	1997-07-24	Derives de 3-(bis-phenylmethylene substitue) oxindole
JP2021525784A (ja)	2021-09-27	チエノ［２，３−ｃ］ピリダジン−４（１Ｈ）−オン系誘導体及びその使用
JPH07300455A (ja)	1995-11-14	３−フェニルピロリジン誘導体
CN108290868B (zh)	2021-06-01	1,4-二-(4-甲硫基苯基)-3-邻苯二甲酰氮杂环丁烷-2-酮及其衍生物
PL103784B1 (pl)	1979-07-31	Sposob wytwarzania nowej pochodnej fenylopirydyloaminy
SU1421259A3 (ru)	1988-08-30	Способ получени производных 2-(2-тиенил)-имидазо/4,5- @ /пиридина или их фармацевтически пригодных аддитивных солей с кислотами
CA1304369C (en)	1992-06-30	Azoniaspironortropanol esters and processes for the preparation thereof
JPS5910359B2 (ja)	1984-03-08	シンキナチツソガンユウタカンカゴウブツノチヨウセイホウホウ
FI114155B (fi)	2004-08-31	Migreenin hoitoon käytettävä indolijohdannainen
JPH0358953A (ja)	1991-03-14	（ｓ）―５―ヒドロキシデカン酸およびそれを有効成分とする医薬組成物
NO840545L (no)	1984-08-16	Imidazolderivater
WO1990001483A1 (en)	1990-02-22	Tetrahydropyridine derivatives
JPS622583B2 (xx)	1987-01-20